Equities

Invitro International

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IVRO:QBB

Invitro International

Actions
  • Price (USD)0.075
  • Today's Change-0.039 / -34.21%
  • Shares traded127.00k
  • 1 Year change-16.67%
  • Beta-0.8032
Data delayed at least 15 minutes, as of Feb 11 2026 20:34 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Invitro International is a technology-driven provider of non-animal testing methods. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. It operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.

  • Revenue in USD (TTM)716.89k
  • Net income in USD6.22k
  • Incorporated1985
  • Employees16.00
  • Location
    Invitro International330 E Orangethorpe Ave Ste DPLACENTIA 92870United StatesUSA
  • Phone+1 (949) 851-8356
  • Fax+1 (949) 851-4985
  • Websitehttps://www.invitrointl.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pure Harvest Corporate Group Inc2.48m-6.67m861.66k25.00--0.3823--0.3479-0.0901-0.09010.03830.02010.26441.4640.6499,070.40-70.96---136.76--33.83---268.37--0.5886-0.8660.7639--1,808.41---459.26------
ITonis Inc0.00-1.17m914.05k-----------0.0012-0.00120.00-0.00040.00-------187.63---1,169.36-------------0.8999---------506.86------
Vitalibis Inc243.57k-3.96m986.42k0.00------4.05-0.1103-0.11030.0034-0.00690.52010.352-----844.71-1,100.84----51.56---1,624.14-2,623.600.5512-2.33----490.69---207.18------
Evofem Biosciences Inc17.73m-5.56m1.14m32.00------0.0643-0.058-0.0580.0111-0.56610.93922.253.61553,937.50-28.79-177.41----80.0569.60-30.66-602.270.0797-0.2439----6.28---117.93---38.87--
American Green Inc-100.00bn-100.00bn1.30m6.00------------------------------------------------------------
Procyon Corp4.98m-312.97k1.53m19.00--0.7027--0.307-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
InVitro International716.89k6.22k1.67m16.00214.292.33--2.330.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Panacea Life Sciences Holdings Inc2.76m-7.67m1.90m40.00------0.6858-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.122.58--46.59--12.33------
Universe Pharmaceuticals Inc17.86m-3.67m2.04m216.00--0.0363--0.1142-10.13-10.1339.1899.640.26025.881.3882,679.35-5.35-5.40-7.08-7.0935.2843.33-20.56-9.653.90-17.460.1416---22.44-10.2757.92--46.30--
Bio Essence Corp565.67k-160.45k2.08m2.00------3.67-0.0042-0.00420.0149-0.08161.26--16.06282,835.00-35.64-40.94----69.2838.36-28.36-134.00---57.42-------17.08-286.98------
SOHM Inc-100.00bn-100.00bn2.44m--------------------------------------------------------------
Data as of Feb 11 2026. Currency figures normalised to Invitro International's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.